Investing

The company will use the funds to expand nationally, enhance its technology platform and advance clinical innovation.

The funds will be used to expand its direct-to-consumer services and grow partnerships with payers and health systems.

The round follows a $200 million seed raise earlier this year.

The company will use the funds to invest in AI research and development initiatives.

The company's AI voice companion allows seniors to engage in conversation via a telephone that does not require additional devices or hardware.

The funding round comes one month after the company announced it secured a $35 million investment.

The company will use the funds for the global introduction of its robotic retinal imaging, AI and teleophthalmology platform.

The funds will be used to expand the company's reach with payers and providers, grow its team and for product development.

The company is on track to be live in 10 U.S. states by the end of 2025.

Dr. Atul Gupta, CMO of diagnosis and treatment at Philips, and Kevin Roesch, assistant VP of cardiology and imaging services for Methodist Hospitals, highlight the process of developing interventional labs to support Indiana’s residents.